Evolution of platelet activation parameters during septic shock in intensive care unit

References

• Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J-D, Coopersmith CM, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:801–810. doi:10.1001/jama.2016.0287.
   PubMed Web of Science ®Google Scholar
• Pfeiler S, Massberg S, Engelmann B. Biological basis and pathological relevance of microvascular thrombosis. Thromb Res 2014;133:S35–S37. doi:10.1016/j.thromres.2014.03.016.
   PubMed Web of Science ®Google Scholar
• Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2012;13:34–45. doi:10.1038/nri3345.
   PubMed Web of Science ®Google Scholar
• Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res 2018;122:337–351. doi:10.1161/CIRCRESAHA.117.310795.
   PubMed Web of Science ®Google Scholar
• Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome*. Crit Care Med 2002;30:1765–1771. doi:10.1097/00003246-200208000-00015.
   PubMed Web of Science ®Google Scholar
• Baughman RP, Lower EE, Flessa HC, Tollerud DJ. Thrombocytopenia in the intensive care unit. Chest 1993;104:1243–1247. doi:10.1378/chest.104.4.1243.
   PubMed Web of Science ®Google Scholar
• Housinger TA, Brinkerhoff C, Warden GD. The relationship between platelet count, sepsis, and survival in pediatric burn patients. Arch Surg 1993;128. 65–6– discussion 66–7. doi:10.1001/archsurg.1993.01420130073011.
   PubMedGoogle Scholar
• Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG, The SOFA. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med 1996;22:707–710.
   PubMed Web of Science ®Google Scholar
• Stéphan F, Cheffi MA, Kaplan C, Maillet J, Novara A, Fagon J, Bonnet F. Autoantibodies against platelet glycoproteins in critically ill patients with thrombocytopenia. Am J Med 2000;108:554–560. doi:10.1016/S0002-9343(00)00332-6.
   PubMed Web of Science ®Google Scholar
• Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H. Thrombocytopenia and prognosis in intensive care. Crit Care Med 2000;28:1871–1876. doi:10.1097/00003246-200006000-00031.
   PubMed Web of Science ®Google Scholar
• Thachil J, Warkentin TE. How do we approach thrombocytopenia in critically ill patients? Br. J Haematol 2017;177:27–38. doi:10.1111/bjh.14482.
   Google Scholar
• Greinacher A, Selleng S. How I evaluate and treat thrombocytopenia in the intensive care unit patient. Blood 2016;128:3032–3042. doi:10.1182/blood-2016-09-693655.
   PubMed Web of Science ®Google Scholar
• Yeaman MR. Platelets: at the nexus of antimicrobial defence. Nat Rev Micro 2014;12:426–437. doi:10.1038/nrmicro3269.
   PubMed Web of Science ®Google Scholar
• Zimmerman GA. Two by two: the pairings of P-selectin and P-selectin glycoprotein ligand 1. Proc Natl Acad Sci 2001;98:10023–10024. doi:10.1073/pnas.191367898.
   PubMed Web of Science ®Google Scholar
• Zarbock A, Singbartl K, Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 2006;116:3211–3219. doi:10.1172/JCI29499.
   PubMed Web of Science ®Google Scholar
• Montague SJ, Delierneux C, Lecut C, Layios N, Dinsdale RJ, Lee CSM, Poulter NS, Andrews RK, Hampson P, Wearn CM, et al. Soluble GPVI is elevated in injured patients: shedding is mediated by fibrin activation of GPVI. Blood Adv 2018;2:240–251. doi:10.1182/bloodadvances.2017011171.
   PubMed Web of Science ®Google Scholar
• Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci 1996;93:11877–11882. doi:10.1073/pnas.93.21.11877.
   PubMed Web of Science ®Google Scholar
• Vardon-Bounes F, Mémier V, Marcaud M, Jacquemin A, Hamzeh-Cognasse H, Garcia C, Series J, Sié P, Minville V, Gratacap M-P, et al. Platelet activation and prothrombotic properties in a mouse model of peritoneal sepsis. Sci Rep 2018;8:13536. doi:10.1038/s41598-018-31910-8.
   PubMed Web of Science ®Google Scholar
• Clemetson JM, Polgar J, Magnenat E, Wells TN, Clemetson KJ. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 1999;274:29019–29024. doi:10.1074/jbc.274.41.29019.
   PubMed Web of Science ®Google Scholar
• Jung SM, Moroi M, Soejima K, Nakagaki T, Miura Y, Berndt MC, Gardiner EE, Howes J-M, Pugh N, Bihan D, et al. Constitutive dimerization of glycoprotein VI (GPVI) in resting platelets is essential for binding to collagen and activation in flowing blood. J Biol Chem 2012;287:30000–30013. doi:10.1074/jbc.M112.359125.
   PubMed Web of Science ®Google Scholar
• Loyau S, Dumont B, Ollivier V, Boulaftali Y, Feldman L, Ajzenberg N, Jandrot-Perrus M. Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity. Arterioscler Thromb Vasc Biol 2012;32:778–785. doi:10.1161/ATVBAHA.111.241067.
   PubMed Web of Science ®Google Scholar
• Poulter NS, Pollitt AY, Owen DM, Gardiner EE, Andrews RK, Shimizu H, Ishikawa D, Bihan D, Farndale RW, Moroi M, et al. Clustering of glycoprotein VI (GPVI) dimers upon adhesion to collagen as a mechanism to regulate GPVI signaling in platelets. J Thromb Haemost 2017;15:549–564. doi:10.1111/jth.13613.
   PubMed Web of Science ®Google Scholar
• Weiss LJ, Manukjan G, Pflug A, Winter N, Weigel M, Nagler N, Kredel M, Lâm TT, Nieswandt B, Weismann D, et al. Acquired platelet GPVI receptor dysfunction in critically ill patients with sepsis. Blood 2021;137:3105–3115. doi:10.1182/blood.2020009774.
   PubMed Web of Science ®Google Scholar
• Henn V, Steinbach S, Büchner K, Presek P, Kroczek RA. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001;98:1047–1054. doi:10.1182/blood.V98.4.1047.
   PubMed Web of Science ®Google Scholar
• Henn V, Slupsky JR, Gräfe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591–594. doi:10.1038/35393.
   PubMed Web of Science ®Google Scholar
• Jin Y, Nonoyama S, Morio T, Imai K, Ochs HD, Mizutani S. Characterization of soluble CD40 ligand released from human activated platelets. J Med Dent Sci 2001;48:23–27.
   PubMedGoogle Scholar
• Elzey BD, Ratliff TL, Sowa JM, Crist SA. Platelet CD40L at the interface of adaptive immunity. Thromb Res 2011;127:180–183. doi:10.1016/j.thromres.2010.10.011.
   PubMed Web of Science ®Google Scholar
• Rahman M, Zhang S, Chew M, Syk I, Jeppsson B, Thorlacius H. Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis. J Thromb Haemost 2013;11:1385–1398. doi:10.1111/jth.12273.
   PubMed Web of Science ®Google Scholar
• Lorente L, Martín MM, Varo N, Borreguero-León JM, Solé-Violán J, Blanquer J, Labarta L, Díaz C, Jiménez A, Pastor E, et al. Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis. Crit Care 2009 13 6;2011:15, R97.
   Google Scholar
• Wu Q, Ren J, Hu D, Wu X, Li G, Wang G, Gu G, Chen J, Li R, Li Y, et al. Monocyte subsets and monocyte-platelet aggregates: implications in predicting septic mortality among surgical critical illness patients. Biomarkers 2016;21:509–516. doi:10.3109/1354750X.2016.1160290.
   PubMed Web of Science ®Google Scholar
• Akca S, Haji-Michael P, de Mendonça A, Suter P, Levi M, Vincent J-L. Time course of platelet counts in critically ill patients. Crit Care Med 2002;30:753–756. doi:10.1097/00003246-200204000-00005.
   PubMed Web of Science ®Google Scholar
• Moreau D, Timsit J-F, Vesin A, Garrouste-Orgeas M, de Lassence A, Zahar J-R, Adrie C, Vincent F, Cohen Y, Schlemmer B, et al. Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. Chest 2007;131:1735–1741. doi:10.1378/chest.06-2233.
   PubMed Web of Science ®Google Scholar
• Winning J, Reichel J, Eisenhut Y, Hamacher J, Kohl M, Deigner HP, Claus RA, Bauer M, Lösche W. Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms. Platelets 2009;20:50–57. doi:10.1080/09537100802503368.
   PubMed Web of Science ®Google Scholar
• Rahman M, Gustafsson D, Wang Y, Thorlacius H, Braun OÖ. Ticagrelor reduces neutrophil recruitment and lung damage in abdominal sepsis. Platelets 2014;25:257–263. doi:10.3109/09537104.2013.809520.
   PubMed Web of Science ®Google Scholar
• Akinosoglou K, Alexopoulos D. Use of antiplatelet agents in sepsis: a glimpse into the future. Thromb Res 2014;133:131–138. doi:10.1016/j.thromres.2013.07.002.
   PubMed Web of Science ®Google Scholar
• Eisen DP, Reid D, McBryde ES. Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis. Crit Care Med 2012;40:1761–1767.
   PubMed Web of Science ®Google Scholar
• Eisen DP, Leder K, Woods RL, Lockery JE, McGuinness SL, Wolfe R, Pilcher D, Moore EM, Shastry A, Nelson MR, et al. Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial. Lancet Respir Med 2021;9:186–195. doi:10.1016/S2213-2600(20)30411-2.
   PubMed Web of Science ®Google Scholar